Literature DB >> 16927179

Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.

Deepak Bahl1, Robin H Bogner.   

Abstract

PURPOSE: To quantify the effects of the ratio of indomethacin to Neusilin US2 and the processing humidity on the amorphization kinetics, stability and nature of the interaction.
MATERIALS AND METHODS: A porcelain jar mill with zirconia balls was used to affect conversion of the physical mixtures (48 g) of indomethacin and Neusilin US2 (in the ratios 1:1 to 1:5) to amorphous states at room temperature (25 degrees C) employing either 0% RH or 75% RH. The percent crystallinity in the samples was determined from ATR-FTIR scans chemometrically. The physical stability of these co-ground amorphous powders was evaluated at 40 degrees C/75% RH and 40 degrees C/0% RH.
RESULTS: The lower the ratio of indomethacin to Neusilin US2, the faster is the amorphization during co-grinding. Higher humidity facilitates amorphization with a more pronounced effect at the lower ratio of indomethacin to Neusilin US2. There is further amorphization of some of the partially amorphized samples on storage at 40 degrees C/75% RH for 3 months. Hydrogen bonding and surface interaction between metal ions of Neusilin US2 and indomethacin can explain changes in the FTIR spectra.
CONCLUSIONS: The processing humidity and the ratio of indomethacin to Neusilin US2 are important factors to be considered to affect amorphization during ball milling. Amorphous indomethacin can be stabilized by co-grinding with Neusilin US2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927179     DOI: 10.1007/s11095-006-9062-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Prediction of apparent equilibrium solubility of indomethacin compounded with silica by 13C solid state NMR.

Authors:  Tomoyuki Watanabe; Susumu Hasegawa; Naoki Wakiyama; Akira Kusai; Mamoru Senna
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

2.  Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone.

Authors:  Makiko Fujii; Hideko Okada; Yusuke Shibata; Honami Teramachi; Masuo Kondoh; Yoshiteru Watanabe
Journal:  Int J Pharm       Date:  2005-04-11       Impact factor: 5.875

Review 3.  How does residual water affect the solid-state degradation of drugs in the amorphous state?

Authors:  E Y Shalaev; G Zografi
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

4.  Effects of amorphous silicon dioxides on drug dissolution.

Authors:  K Y Yang; R Glemza; C I Jarowski
Journal:  J Pharm Sci       Date:  1979-05       Impact factor: 3.534

5.  Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method.

Authors:  Hirofumi Takeuchi; Shinsuke Nagira; Hiromitsu Yamamoto; Yoshiaki Kawashima
Journal:  Int J Pharm       Date:  2005-04-11       Impact factor: 5.875

6.  Formation of physically stable amorphous drugs by milling with Neusilin.

Authors:  Manish K Gupta; Adam Vanwert; Robin H Bogner
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

7.  Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage.

Authors:  Manish K Gupta; Robin H Bogner; David Goldman; Yin-Chao Tseng
Journal:  Pharm Dev Technol       Date:  2002-01       Impact factor: 3.133

8.  Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.

Authors:  P Tong; G Zografi
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

9.  Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.

Authors:  Kieran J Crowley; George Zografi
Journal:  J Pharm Sci       Date:  2002-10       Impact factor: 3.534

10.  Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide.

Authors:  P Mura; M Cirri; M T Faucci; J M Ginès-Dorado; G P Bettinetti
Journal:  J Pharm Biomed Anal       Date:  2002-09-05       Impact factor: 3.935

View more
  14 in total

1.  Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.

Authors:  Ambarish H Vadher; Jolly R Parikh; Rajesh H Parikh; Ajay B Solanki
Journal:  AAPS PharmSciTech       Date:  2009-05-15       Impact factor: 3.246

2.  Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.

Authors:  Ying Wang; Qinfu Zhao; Yanchen Hu; Lizhang Sun; Ling Bai; Tongying Jiang; Siling Wang
Journal:  Int J Nanomedicine       Date:  2013-10-22

3.  Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 3: effect of moisture.

Authors:  Ken K Qian; Dale E Wurster; Robin H Bogner
Journal:  Pharm Res       Date:  2012-03-20       Impact factor: 4.200

4.  Multicomponent chemical imaging of pharmaceutical solid dosage forms with broadband CARS microscopy.

Authors:  Christopher M Hartshorn; Young Jong Lee; Charles H Camp; Zhen Liu; John Heddleston; Nicole Canfield; Timothy A Rhodes; Angela R Hight Walker; Patrick J Marsac; Marcus T Cicerone
Journal:  Anal Chem       Date:  2013-08-20       Impact factor: 6.986

5.  A One-Step Twin-Screw Melt Granulation with Gelucire 48/16 and Surface Adsorbent to Improve the Solubility of Poorly Soluble Drugs: Effect of Formulation Variables on Dissolution and Stability.

Authors:  Sandeep Sarabu; Venkata Raman Kallakunta; Arun Butreddy; Karthik Yadav Janga; Srinivas Ajjarapu; Suresh Bandari; Feng Zhang; S Narasimha Murthy; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2021-02-19       Impact factor: 3.246

Review 6.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

7.  Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.

Authors:  Ajmal Zarinwall; Viktor Maurer; Jennifer Pierick; Victor Marcus Oldhues; Julian Cedric Porsiel; Jan Henrik Finke; Georg Garnweitner
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

8.  Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

9.  Dissolution enhancement of chlorzoxazone using cogrinding technique.

Authors:  Mihir K Raval; Jaydeep M Patel; Rajesh K Parikh; Navin R Sheth
Journal:  Int J Pharm Investig       Date:  2015 Oct-Dec

10.  Improvement in Dissolution Rate of Cefuroxime Axetil by using Poloxamer 188 and Neusilin US2.

Authors:  J Sruti; Ch N Patra; S K Swain; S Beg; H R Palatasingh; S C Dinda; M E Bhanoji Rao
Journal:  Indian J Pharm Sci       Date:  2013-01       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.